Veterinary Antimicrobial Susceptibility Testing Market To Reach $1.50 Billion By 2030

Veterinary Antimicrobial Susceptibility Testing Market Growth & Trends

The global veterinary antimicrobial susceptibility testing market size is expected to reach USD 1.50 billion by 2030, registering a CAGR of 5.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising need to curtail AMR in food animals and zoonosis are key drivers for this market. Animals used for food are most susceptible to Antimicrobial Resistance (AMR) as to ensure a quality yield, the animal owners often feed them. These drugs, although they ensure that the animals remain healthy from any infection, may lead to the development of resistance from a variety of microbes over some time. AMR is a growing occurrence in food animals, threatening their health and possibly human health.

A January 2024 study in Nature Communications explored the antimicrobial resistance in food animals in various countries like China, India, Brazil, Chile, and others. Drug resistance of different antimicrobials was studied in species like E.coli & non-typhoidal Salmonella. The study concluded tetracycline had the highest resistance prevalence of 59% in E.coli and 54% in non-typhoidal Salmonella. However, the lowest resistance prevalence was found for cefotaxime, i.e., 33% & 19%, respectively, in E.coli & non-typhoidal Salmonella. The surveillance study also classified the AMR into regional locations. For instance, pathogens from 78% of locations studied in African & South American regions were resistant to penicillin or tetracyclines. On the other hand, in Asia, pathogens from 77% of locations were resistant to penicillin or sulphonamides.

This highlights the significant prevalence of antimicrobial resistance in food animals across the globe, increasing the emphasis on the urgent need for effective antimicrobial susceptibility testing products. As AMR threatens animal and human health, a rise in demand for appropriate testing solutions to combat this resistance will be experienced. The demand for advanced testing technologies among veterinary professionals to accurately assess antimicrobial susceptibility patterns will increase, driving the market growth.

Artificial Intelligence (AI) is another potential driving factor for the market owing to industry developments focused on integrating AI into veterinary AST. For instance, in November 2023, the University of Oxford's Oxford Martin Programme on Antimicrobial Resistance Testing displayed AI's capability of detecting antimicrobial resistance in only 30 minutes. Such developments paint a promising picture of market growth.

 Request a free sample copy or view report summary: Veterinary Antimicrobial Susceptibility Testing Market Report

Veterinary Antimicrobial Susceptibility Testing Market Report Highlights

• Based on animal type, the production animal segment dominated the market with a revenue share of over 66.7% in 2023 owing to rising consumption of animal products and usage of antibiotics in food animals

• Based on product, automated AST instruments segment is attributed to the largest revenue share in 2023 owing to the rising adoption of these instruments in various veterinary laboratories and institutes as well as their higher cost in comparison to other products.

• Based on end use, the veterinary reference laboratories segment held the highest revenue share of 58.14% in 2023 as more number of AST samples are tested in these facilities as per directions from the veterinary professionals.

• Asia Pacific held the largest revenue share of 34.51% of the global market in 2023. This can be attributed to the presence of the highest amount of livestock population in this region.

• Factors such as the rising regulatory & training initiatives among leading veterinary organizations, the growing potential of Artificial Intelligence (AI) in AST, the rising livestock population, and growing antimicrobial resistance (AMR) among animals are expected to drive market growth.

Veterinary Antimicrobial Susceptibility Testing Market Segmentation

Grand View Research has segmented the global veterinary antimicrobial susceptibility testing market based on animal type, product, end-use, and region. 

Veterinary Antimicrobial Susceptibility Testing Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Production Animal

  • Cattle

  • Poultry

  • Pigs

  • Others (sheep, goats, veal)

• Companion Animal

  • Dogs

  • Cats

  • Equine

  • Others (Birds, Fish, Turtles)

Veterinary Antimicrobial Susceptibility Testing Product Outlook (Revenue, USD Million, 2018 - 2030)

• Disks & Plates

• Culture Media

• Accessories & Consumables

• Automated AST Instruments

Veterinary Antimicrobial Susceptibility Testing End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Veterinary Reference Lab

• Vet Research Institutes

• Others (Vet Hospitals, Pet Clinics, Point of Care Testing)

Veterinary Antimicrobial Susceptibility Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

List of Key Players in the Veterinary Antimicrobial Susceptibility Testing Market

• BioMérieux SA

• Becton, Dickinson and Company

• Synbiosis

• Thermo Fisher Scientific

• Bruker Corporation

• Danaher Corporation (Beckman Coulter Inc.)

• Condalab

• Bioguard Corporation

• Liofilchem S.r.l.

• HiMedia Laboratories

• Bio-Rad Laboratories